Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells
Journal article
Baugh R. et al, (2024), Journal for ImmunoTherapy of Cancer, 12, e008460 - e008460
The British Society for Gene and Cell Therapy at 20 (2003–2023)
Journal article
Seymour L. et al, (2024), Human Gene Therapy, 35, 5 - 8
Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent?
Journal article
Wan PK-T. et al, (2023), J Immunother Cancer, 11
Optogenetically Engineered Neurons Differentiated from Human SH-SY5Y Cells Survived and Expressed ChR2 in 3D Hydrogel
Journal article
Lee S-Y. et al, (2022), Biomedicines, 10, 1534 - 1534
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination.
Journal article
Su W. et al, (2022), Nat Commun, 13
Deregulation of HLA-I in cancer and its central importance for immunotherapy.
Journal article
Hazini A. et al, (2021), J Immunother Cancer, 9
Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus.
Journal article
Wan PK-T. et al, (2021), Mol Ther, 29, 1668 - 1682
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy.
Journal article
Khalique H. et al, (2021), J Immunother Cancer, 9
Tackling HLA Deficiencies Head on with Oncolytic Viruses.
Journal article
Fisher K. et al, (2021), Cancers (Basel), 13
Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response.
Journal article
Baugh R. et al, (2020), Cancers (Basel), 12
Development of a novel mammalian display system for selection of antibodies against membrane proteins.
Journal article
Robertson N. et al, (2020), J Biol Chem
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR).
Journal article
O'Cathail SM. et al, (2020), Radiat Oncol, 15
A Complete "Self-Repressing" Adenovirus System Enables Efficient Manufacture of Adeno-Associated Viral Vectors without Contamination by Adenovirus or Small Drugs
Conference paper
Su W. et al, (2020), MOLECULAR THERAPY, 28, 240 - 240
Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion.
Journal article
Yousaf I. et al, (2020), Cancers (Basel), 12
External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase.
Journal article
Pokrovska TD. et al, (2020), Cancers (Basel), 12
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens.
Journal article
Lynn GM. et al, (2020), Nat Biotechnol, 38, 320 - 332
The role of cancer metabolism in defining the success of oncolytic viro-immunotherapy
Journal article
Dyer A. et al, (2020), Cytokine and Growth Factor Reviews
Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation.
Journal article
Taverner WK. et al, (2019), Mol Ther Oncolytics, 15, 117 - 130
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.
Journal article
Scott EM. et al, (2019), J Immunother Cancer, 7
Nanomedicines for the Delivery of Biologics.
Journal article
Wahlich J. et al, (2019), Pharmaceutics, 11